{
    "medicine_id": "7844d66a887794b0c797a17f8a4bf091689f95bc",
    "platform_id": "DB06817",
    "metadata": {
        "name": "Dutrebis 150 MG Tablet film coated",
        "composition": "150 MG Raltegravir",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of HIV 1 infection in conjunction with other antiretrovirals",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00175",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Raltegravir is combined with Pravastatin"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Raltegravir is combined with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Raltegravir is combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Raltegravir is combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Raltegravir is combined with Atorvastatin"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Raltegravir is combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Raltegravir is combined with Rosuvastatin"
                    },
                    {
                        "drugbank-id": "DB06693",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Raltegravir is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "The risk or severity of myopathy and rhabdomyolysis can be increased when Raltegravir is combined with Pitavastatin"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "Omeprazole can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "Lansoprazole can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB00736",
                        "description": "Esomeprazole can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Rabeprazole can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB05351",
                        "description": "Dexlansoprazole can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB13762",
                        "description": "Dexrabeprazole can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB11964",
                        "description": "Ilaprazole can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB00615",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Rifabutin"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Sucralfate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00516",
                        "description": "Bentoquatam can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "Magnesium sulfate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "Magnesium salicylate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01575",
                        "description": "Kaolin can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01593",
                        "description": "Zinc can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02165",
                        "description": "Zinc trihydroxide can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04249",
                        "description": "Zinc Substituted Heme C can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09087",
                        "description": "Potassium alum can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09221",
                        "description": "Polaprezinc can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09321",
                        "description": "Zinc oxide can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09322",
                        "description": "Zinc sulfate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Magnesium chloride can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11081",
                        "description": "Aluminum chloride can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "Magnesium citrate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "Zinc citrate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11175",
                        "description": "Zinc picolinate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11239",
                        "description": "Aluminum sulfate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11248",
                        "description": "Zinc gluconate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11306",
                        "description": "Bentonite can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13359",
                        "description": "Magnesium aspartate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13654",
                        "description": "Montmorillonite can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13749",
                        "description": "Magnesium gluconate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13786",
                        "description": "Magnesium orotate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14479",
                        "description": "Acetylcysteine zinc can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14485",
                        "description": "Zinc ascorbate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14487",
                        "description": "Zinc acetate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14493",
                        "description": "Zinc glycinate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "Magnesium can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14514",
                        "description": "Magnesium levulinate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14515",
                        "description": "Magnesium lactate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14533",
                        "description": "Zinc chloride can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14548",
                        "description": "Zinc sulfate unspecified form can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14532",
                        "description": "Zinc cation can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Raltegravir can be increased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Raltegravir can be increased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "The metabolism of Raltegravir can be increased when combined with Desogestrel"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The metabolism of Raltegravir can be increased when combined with Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The metabolism of Raltegravir can be increased when combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The metabolism of Raltegravir can be increased when combined with Lamotrigine"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Raltegravir can be increased when combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The metabolism of Raltegravir can be increased when combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The metabolism of Raltegravir can be increased when combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Raltegravir can be increased when combined with Tipranavir"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The metabolism of Raltegravir can be increased when combined with Ethinylestradiol"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Raltegravir can be increased when combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "The metabolism of Raltegravir can be increased when combined with Testosterone propionate"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Amprenavir"
                    },
                    {
                        "drugbank-id": "DB01319",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Fosamprenavir"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01390",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Sodium bicarbonate"
                    },
                    {
                        "drugbank-id": "DB06723",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Calcium carbonate"
                    },
                    {
                        "drugbank-id": "DB08938",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Magaldrate"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Magnesium hydroxide"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Magnesium trisilicate"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Magnesium carbonate"
                    },
                    {
                        "drugbank-id": "DB13209",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13249",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13280",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Aluminium acetoacetate"
                    },
                    {
                        "drugbank-id": "DB13322",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Hydrotalcite"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Magnesium peroxide"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Almasilate"
                    },
                    {
                        "drugbank-id": "DB13626",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Aluminium glycinate"
                    },
                    {
                        "drugbank-id": "DB13650",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Aloglutamol"
                    },
                    {
                        "drugbank-id": "DB13829",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Calcium silicate"
                    },
                    {
                        "drugbank-id": "DB14517",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Aluminium phosphate"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Leuprolide is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00052",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Somatotropin is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Infliximab is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Daptomycin is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cyclosporine is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Baclofen is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Sildenafil is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cladribine is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Pamidronic acid is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mefloquine is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Tacrine is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Carbimazole is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Trimethoprim is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Betamethasone is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00471",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Montelukast is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Lercanidipine is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ciprofloxacin is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Vincristine is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Propylthiouracil is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Methotrexate is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Enalapril is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00602",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ivermectin is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Chloroquine is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Triamcinolone is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Niacin is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Alendronic acid is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00636",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Clofibrate is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00649",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Stavudine is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00666",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Amphotericin B is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mycophenolate mofetil is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Naltrexone is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ibandronate is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Terbinafine is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Penicillamine is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Tacrolimus is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Eprosartan is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Risedronic acid is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Bumetanide is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Triazolam is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ethanol is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Salmeterol is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Isoniazid is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Methyldopa is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Isotretinoin is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cytarabine is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ganciclovir is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01006",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Letrozole is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Sulfamethoxazole is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Minocycline is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Procainamide is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Fenofibrate is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Norfloxacin is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Iloprost is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Leflunomide is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Amiodarone is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ofloxacin is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Procarbazine is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Captopril is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Paclitaxel is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Saquinavir is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Metoclopramide is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Dexamethasone is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Docetaxel is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01393",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Bezafibrate is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Colchicine is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Fusidic acid is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Trabectedin is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB08983",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Etofibrate"
                    },
                    {
                        "drugbank-id": "DB09055",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Acipimox"
                    },
                    {
                        "drugbank-id": "DB09064",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Ciprofibrate"
                    },
                    {
                        "drugbank-id": "DB09270",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Ipecac"
                    },
                    {
                        "drugbank-id": "DB13393",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Emetine"
                    },
                    {
                        "drugbank-id": "DB13433",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Simfibrate"
                    },
                    {
                        "drugbank-id": "DB13460",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Ronifibrate"
                    },
                    {
                        "drugbank-id": "DB13780",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Aluminium clofibrate"
                    },
                    {
                        "drugbank-id": "DB13849",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Clofibride"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Raltegravir is combined with Fenofibric acid"
                    },
                    {
                        "drugbank-id": "DB00173",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Adenine"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Indinavir"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Flurbiprofen"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Propofol"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Atazanavir"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Eltrombopag"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Dasabuvir"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Sodium aurothiomalate"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Ombitasvir"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Paritaprevir"
                    },
                    {
                        "drugbank-id": "DB09298",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Silibinin"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Ertugliflozin"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Fostamatinib"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Pibrentasvir"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Glecaprevir"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "The metabolism of Raltegravir can be decreased when combined with Pexidartinib"
                    },
                    {
                        "drugbank-id": "DB10317",
                        "description": "The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB10343",
                        "description": "The therapeutic efficacy of Bacillus calmette guerin substrain tice live antigen can be decreased when used in combination with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB10804",
                        "description": "The therapeutic efficacy of Bacillus calmette guerin substrain connaught live antigen can be decreased when used in combination with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB10805",
                        "description": "The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB11003",
                        "description": "The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB11050",
                        "description": "The therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB12386",
                        "description": "The therapeutic efficacy of Bacillus calmette guerin substrain danish 1331 live antigen can be decreased when used in combination with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB14409",
                        "description": "The therapeutic efficacy of Human adenovirus e serotype 4 strain cl 68578 antigen can be decreased when used in combination with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB14685",
                        "description": "The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB10318",
                        "description": "The therapeutic efficacy of Varicella Zoster Vaccine Live attenuated can be decreased when used in combination with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "Cimetidine can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "Nizatidine can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "Ranitidine can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "Famotidine can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "Methantheline can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB08805",
                        "description": "Metiamide can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB08806",
                        "description": "Roxatidine acetate can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB12770",
                        "description": "Lafutidine can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB12884",
                        "description": "Lavoltidine can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB13760",
                        "description": "Niperotidine can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB15246",
                        "description": "Salvianolic acid A can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB14048",
                        "description": "Sodium zirconium cyclosilicate can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB01370",
                        "description": "Aluminium can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects"
                    },
                    {
                        "drugbank-id": "DB01378",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Magnesium cation"
                    },
                    {
                        "drugbank-id": "DB11093",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Calcium citrate"
                    },
                    {
                        "drugbank-id": "DB11135",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Selenium"
                    },
                    {
                        "drugbank-id": "DB13257",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Ferrous sulfate anhydrous"
                    },
                    {
                        "drugbank-id": "DB13949",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Ferric cation"
                    },
                    {
                        "drugbank-id": "DB14488",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Ferrous gluconate"
                    },
                    {
                        "drugbank-id": "DB14490",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Ferrous ascorbate"
                    },
                    {
                        "drugbank-id": "DB14577",
                        "description": "The serum concentration of Raltegravir can be decreased when it is combined with Calcium cation"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}